Abstract
When von Euler (1) first described the prostaglandins thirty years ago, he could not have imagined that these lipids would be implicated in so many physiologic roles. With the rediscovery of these lipids and the elucidation of their chemical structure by Bergstrom and Samuelsson (2), a considerable volume of information has been generated. The prostaglandins are a group of 20-carbon acidic lipids generally resembling prostanoic acid. They are derived from the enzymatic conversion of either linolenic acid (the 1-series) or arachidonic acid (the 2-series) (3,4). During their synthesis, numerous short-lived cyclic endoperoxide intermediates are formed which by themselves are frequently more active than the prostaglandins (5). Almost every cell in the body has the capacity to synthesize prostaglandins although in the adult, the major organs of synthesis are the renal medulla, seminal vesicles, and uterus. The prostaglandins that are synthesized in the microsomes are probably not stored by the cell (6), but released into the cytoplasm and eventually into the extracellular fluid. The lung, liver, and renal cortex among other tissues, have the enzymatic ability to degrade prostaglandins (7). Although dozens of prostaglandins, intermediates, and metabolites have been identified, prostaglandin-E2 (PGE2) and prostaglandin-F2∝ (PGF2∝) appear to be implicated as the active naturally occurring agents. The prostaglandins can be identified and measured by various techniques with considerable variation in sensitivity and specificity (8). These methods include gas chromatography and mass spectrometry, thin layer chromatography, radioimmunoassay, membrane receptor assay, and bioassay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
von Euler, U.S.: On the specific vasodilating and plain muscle stimulating substances from accessory genital glands in man and certain animals. J. Physiol. 88: 213, 1937.
Bergstrom, S., Ryhage, R., Samuelsson, B., and Sjovall, J.: The structure of prostaglandin E, F, and F2. Acta. Chem. Scand. 16: 501, 1962.
Bergstrom, S., Danielsson, H., and Samuelsson, B.: The enzymatic formation of prostaglandin E2 from arachidonic acid. Biochim. Biophys. Acta. 90: 207, 1964.
Van Dorp, D.A., Beerthuis, R.K., Nugteren, D.H., and Vonkeman, H.: The biosynthesis of prostaglandins. Biochim. Biophys. Acta. 90: 204, 1964.
Samuelsson, B. and Ramberg, M.: Role of endoperoxides in the biosynthesis and action of prostaglandins. In: Prostaglandin Synthetase Inhibitors, eds. H.J. Robinson and J.R. Vane, Raven Press, New York, 1974, p. 107–121.
Crowshaw, K.: The incorporation of {1–14C} arachidonic acid into the lipids of rabbit renal slices and conversion to prostaglandins E2 and F2«. Prostaglandins. 3: 607, 1973.
Ferreira, S.H. and Vane, J.R.: Prostaglandins: their disappearance from and release into the circulation. Nature (Lond.). 216: 868, 1967.
Frolich, J.C., Williams, W.M., Sweetman, B.J., Smigel, M., Carr, K., Hollifield, J.W., Fleisher, S., Nies, A.S., Frisk-Holmberg, M., and Oates, J.A.: Analysis of renal prostaglandin synthesis by competitive protein binding assay and gas chromatography - mass spectrometry. In: Advances in Prostaglandin and Thromboxane Research, Vol. 1, eds. B. Samuelsson and R. Paoletti, Raven Press, New York, 1976.
Golub, M., Zia, P., Matsuno, M., and Horton, R.: Metabolism of prostaglandins Al and E1 in man. J. Clin. Invest. 56: 1404, 1975.
Venuto, R.C., O’Dorisio, T., Stein, J.H., and Ferris, T.F.: Uterine prostaglandin E secretion and uterine blood flow in the pregnant rabbit. J. Clin. Invest. 55: 193, 1975.
Berl, T. and Schrier, R.W.: The mechanism of effect of prostaglandin E1 on renal water excretion. J. Clin. Invest. 52: 463, 1973.
Willis, A.L., Davison, P., Ramwell, P.W., Brocklehurst, W.E., and Smith, J.B.: Release and action of prostaglandins in inflammation and fever: Inhibition by anti-inflammatory and antipyretic drugs. In: Prostaglandins in Cellular Biology, eds. P.W. Ramwell and B.B. Pharriss, Plenum Press, New York, 1972, p. 227–259.
Klein, D.C. and Raisz, L.G.: Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology. 86: 1436, 1970.
Franklin, R.B. and Tashjian, A.H.: Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. Endocrinology. 97: 240, 1975.
Goodson, J.M., Dewhirst, F.E., and Brunetti, A.: Prostaglandin EZZ levels and human periodontal disease. Prostaglandins. 6: 8 I, 1974.
Harris, M., Jenkins, M.U., Bennett, A., and Wills, M.R.: Prostaglandin production and bone resorption by dental cysts. Nature. 245: 213, 1973.
Goldhaber, P., Rabadjija, L., Beyer, W.R., and Kornhauser, G.: Bone resorption in tissue culture and its relevance to periodontal disease. J. Amer. Dent. Assoc. (Special Issue). 87: 1027, 1973.
Gomes, B.C., Hausmann, E., Weinfeld, N., and De Luca, C.: Prostaglandins: bone resorption stimulating factors released from monkey gingiva. Calcif. Tiss. Res. 19: 285, 1976.
Feinblatt, J.D., Tai, L.-R., and Leone, R.G.: Secretion of a bone resorbing factor by chick thyroid glands in organ culture. Endocrinology. 99: 1363, 1976.
Tashjian, A.H., Voelkel, E.F., Levine, L., et al.: Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2: a new model for the hypercalcemia of cancer. J. Exp. Med. 136: 1329, 1972.
Voelkel, E.F., Tashjian, A.H., Franklin, R., Wasserman, E., and Levine, L.: Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. Metabolism. 24: 973, 1975.
Seyberth, H.W., Segre, G.V., Morgan, J.L., Sweetman, B.J., Potts, J.T., and Oates, J.A.: Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N. Engl. J. Med. 293: 1278, 1975.
Robertson, R.P., Baylink, D.J., Metz, S.A., and Cummings, K.B.: Plasma prostaglandin E in patients with cancer with and without hypercalcemia. J. Clin. Endocrinol. Metab. 43: 1330, 1976.
Dindogru, A., Gailani, S., Henderson, F.S., Wallace, H.J., and Fitzpatrick, J.: Indomethacin in hypercalcemia. Lancet. 1: 1218, 1975.
Ito, H., Sanada, T., Katayama, T., and Shimazaki, J.: Indomethacin-responsive hypercalcemia. N. Engl. J. Med. 293: 558, 1975.
Vogel, S.B., Enneking, W.F., and Thomas, W.C.: Effect of thyroparathyroidectomy in hypercalcemia associated with malignancy. Endocrinology. 80: 404, 1967.
Gill, J.R., Frolich, J.C., Bowden, R.E., Taylor, A.A., Keiser, H.R., Seyberth, J., Hannsjorg, W., Oates, J.A., and Bartter, F.C.: Bartter’s syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am. J. Med. 61: 43, 1976.
Yu, J.H., Wells, H., Ryan, W.J., and Lloyd, W.S.: Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells. Prostaglandins. 12: 501, 1976.
Kohlhardt, M., Bauer, B., Krause, H., and Fleckenstein, A.: Differentiation of transmembrane Na and Ca channels in mammalian cardiac fibers by the use of specified inhibitors. Pflueger Arch. 335: 309, 1972.
Raisz, L.G. and Koolemans-Beynen, A.R.: Inhibition of bone collagen synthesis by prostaglandin E2 organ culture. Prostaglandins. 8: 377, 1974.
Roos, B.A., Bundy, L.L., Miller, E.A., and Deftos, L.J.: Calcitonin secretion by monolayer cultures of human C-cells derived from medullary thyroid carcinoma. Endocrinology. 97: 39, 1975.
Amer, M.A. and Marquis, N.R.: The effect of prostaglandins, epinephrine and aspirin on cyclic AMP phosphodiesterase activity of human blood platelets and their aggregation. In: Prostaglandins in Cellular Biology, eds. P.W. Ramwell and B.B. Pharris, Plenum Press, New York, 1972.
Johnson, M. and Ramwell, P.W.: Prostaglandin modification of membrane-bound enzyme activity: a possible mechanism of action. Prostaglandins. 3: 703, 1973.
Hinman, J.W.: Prostaglandins. Ann. Rev. Biochem. 41: 161, 1972.
Hamprecht, B., Jaffe, B.M., Philpott, A.W.: Prostaglandin production by neuroblastoma, glioma and fibroblast cell line. FEBS Lets. 36: 193, 1973.
Dalton, C. and Hope, W.C.: Cyclic AMP regulation of PG bio-synthesis in fat cells. Prostaglandins. 6: 227, 1974.
Burke, G., Chang, L., and Szabo, M.: Thyrotropin and cyclic nucleotide effects on prostaglandin levels in isolated thyroid cells. Science. 180: 872, 1973.
Carsten, M.E. and Miller, J.D.: Effect of prostaglandins and oxytocin on calcium release from a uterine microsomal fraction. J. Biol. Chem. 252: 1576, 1977.
Moura, A.-M. and Simpkins, H.: The effects of hormones and prostaglandins on the calcium pools in cultured myocardial cells. Mol. Cell. Endocrinol. 5: 349, 1976.
Ishizawa, M. and Miyazaki, E.: Calcium and the contractile response to prostaglandin in the smooth muscle of guinea-pig stomach. Experientia. 33: 376, 1976.
Hilborn, D.A.: Serum stimulation of phosphate uptake into 3T3 cells. J. Cell. Physìol. 87: 111, 1975.
Moncada, S., Higgs, E.A., and Vane, J.R.: Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet. 1: 18, 1977.
Boelens, P.A., Norwood, W.K., and Kjellstrand, C.: Hypophosphatemia with muscle weakness due to antacids and hemodialysis. Am. J. Dis. Child. 120: 350, 1970.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Kirschenbaum, M.A., Kleeman, C.R. (1978). Prostaglandins and Divalent Cation Metabolism. In: Massry, S.G., Ritz, E., Rapado, A. (eds) Homeostasis of Phosphate and Other Minerals. Advances in Experimental Medicine and Biology, vol 103. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7758-0_31
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7758-0_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7760-3
Online ISBN: 978-1-4684-7758-0
eBook Packages: Springer Book Archive